tbuckley/cabot-search huggingface dataset:
<i>PHF6</i> Mutation in Chronic Myelomonocytic Leukemia Is Associated with Chronic Thrombocytopenia and Predicts Superior Overall and Leukemia-Free Survival
Authors: Saubia Fathima, Ali Alsugair, Anuya A. Natu, Clifford M. Csizmar, Mark Gurney, Terra L. Lasho, Christy Finke, Abhishek A. Mangaonkar, Kaaren K. Reichard, Rong He, Animesh D. Pardanani, Naseema Gangat, Mrinal M. Patnaik, Ayalew Tefferi
Journal: Blood (2024)
Effect of Talquetamab on Responses in Patients with Relapsed and Refractory Multiple Myeloma with Prior Exposure to T-Cell Redirecting Therapies
Authors: Omar Castaneda, Doris K. Hansen, Mariola A Vazquez-Martinez, Shrikar Modukuri, Brandon Blue, Julia Fadul, Ariel Denson, Parker Melnick, Filip Ionescu, Kristy Harvey, Blanca Lopez, Katherine Tobon, Hien Liu, Jose L. Ochoa-Bayona, Ciara Louise Freeman, Taiga Nishihori, Kenneth H. Shain, Rachid Baz, Melissa Alsina, Ariel Grajales-Cruz, Allison Graeter, Frederick Locke
Journal: Blood (2024)
Factors Associated with Quality of Life Impairments in Patients with Myeloproliferative Neoplasms: Looking Beyond Symptom Burden
Authors: Chi-Joan How, Bridget Coffey, Christina M. Dieli-Conwright, Gabriela S. Hobbs, Hermioni L Amonoo, Areej El-Jawahri, Richard Newcomb
Journal: Blood (2024)
Initial Results from the QTc Substudy of the IMerge Phase 3 Trial Demonstrate Clinically Meaningful Efficacy, Manageable Safety, and Absence of Proarrhythmic Risk in Patients with Lower-Risk Myelodysplastic Syndromes Who Received Prior Therapies Beyond Erythropoiesis Stimulating Agents
Authors: Rami S. Komrokji, Valeria Santini, Uwe Platzbecker, Koen Van Eygen, Maria Diez-Campelo, Raquel De Paz, Guillermo Sanz, Sylvain Thépot, Maciej Kaźmierczak, Esther Natalie Oliva, Mikkael A. Sekeres, Pierre Fenaux, Yazan F. Madanat, Michael R. Savona, Jennifer Riggs, Souria Dougherty, Ashley Lennox, Qi Xia, Libo Sun, Tymara Berry, Amer M. Zeidan
Journal: Blood (2024)
PIEZO1 Gain-of-Function Variants Lead to Alterations in Late-Stage Erythropoiesis By Enhancing Enucleation Rate
Authors: Barbara Eleni Rosato, Antonella Nostroso, Vanessa D'Onofrio, Roberta Marra, Federica Maria Esposito, Vincenza Cerbone, Lucia De Franceschi, Achille Iolascon, Roberta Russo, Immacolata Andolfo
Journal: Blood (2024)
A Multi-Center Retrospective Study on Complex Karyotype in Patients with Richter Transformation Who Received No Chemoimmunotherapy for Their CLL
Authors: Cecelia Miller, Ying Huang, John N. Allan, Seema A. Bhat, David A. Bond, Danielle M. Brander, John C. Byrd, Julio C. Chavez, Elise A. Chong, Alexey Danilov, Mark R Dowling, Kaitlyn M. Dvorak-Kornaus, Paul J. Hampel, Carrie I Ho, Prioty Islam, Nikita Malakhov, Matthew Matasar, Sarah Miller, Sameer A. Parikh, Kari G. Rabe, Joanna M. Rhodes, Lindsey Roeker, Kerry A. Rogers, Aditi Saha, Alan P Skarbnik, Hamish W Scott, Jake Schade, Mazyar Shadman, Geoffrey Shouse, Deborah M. Stephens, Meghan C. Thompson, Philip A. Thompson, Yucai Wang, Jennifer A. Woyach, Max Yano, Zulfa Omer, Adam S Kittai
Journal: Blood (2024)
Inhibition of Cyclin-Dependent Kinase 9 Rapidly Induces Apoptosis in Acute Lymphoblastic Leukemia and Shows Synergistic Activity with BH3-Mimetics
Authors: Colin Fortner, Alexandra Niedermayer, Stefanie Enzenmüller, Klaus-Michael Debatin, Felix Seyfried, Lüder Hinrich Meyer
Journal: Blood (2024)
Treatment Adherence, Satisfaction and Quality of Life of Adult Patients with Severe Haemophilia a: Results from a Real-World Survey of Physicians and Patients
Authors: Valeria Merla, Sheena Thakkar, Jasmine Healy, Ella Morton, Kieran Wynne-Cattanach, Nathan Ball, Sophie Lai, Chris Blazos, Hanna Salehi
Journal: Blood (2024)
Risk Factors Associated with Sub-Optimal Outcomes Following Obecabtagene autoleucel (obe-cel) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): What We Have Learned from the FELIX Trial
Authors: Claire Roddie, Jae H. Park, Paul Shaughnessy, Aaron C. Logan, Karamjeet S Sandhu, Mehrdad Abedi, Bijal D Shah, Michael R Bishop, Daniel J. DeAngelo, Wolfram Brugger, Martin A Pule, Justin Shang, Elias Jabbour
Journal: Blood (2024)
Infections in Patients with Relapsed/Refractory Multiple Myeloma in the United States: A Real-World Analysis
Authors: Fidelia Ida, Bharat Ramakrishna, Kaz Nasserinejad, Adriana Radu, John-Philip Lawo, Xiang Zhang, David Gardiner, Lara Yoon, Elizabeth C. Dabrowski, John Shen, Monica Iyer, Hannah Kreisberg, Gabriela Espinoza, Zainab Shahid, Sergio A. Giralt
Journal: Blood (2024)
Hodgkin Lymphoma Transformation in Patients Who Received No Prior Chemotherapy for CLL/SLL: Outcomes from a Multicenter Retrospective Study in the Modern Era of Therapy
Authors: Paul J. Hampel, Ying Huang, Sarah Miller, John N. Allan, Seema A Bhat, David A. Bond, Danielle M. Brander, John C. Byrd, Julio C. Chavez, Elise A. Chong, Alexey Danilov, Matthew S. Davids, Kaitlyn M. Dvorak-Kornaus, Hannah Freedman, Nikita Malakhov, Matthew Matasar, Cecelia Miller, Sameer A. Parikh, Erin M. Parry, Kari G. Rabe, Phil Raess, Manoj Rai, Joanna M. Rhodes, Kerry A. Rogers, Aditi Saha, Jake Schade, Geoffrey Shouse, Stephen E Spurgeon, Deborah M. Stephens, Yucai Wang, Jennifer A. Woyach, Max Yano, Omer Zulfa, Adam S Kittai
Journal: Blood (2024)
A Regulated Cytokine Engineering Strategy to Augment <i>in Vitro</i> and <i>In Vivo</i> persistence of Allogeneic iPSC Derived CD8 T-Cells
Authors: Siddarth Chandrasekaran, Justin Yoo, Dhaarini Murugan, Laura Prochazka, Elisa Martinez, Michael Hunter Cadell, Muluken S Belew, Amanda AuYeung, Chris Saxby, Omar Subedar, Zahra Sahaf, Dylan Lee, Sommer Apelu, Libin Abraham, Valerie Wall, Chloe Hurling, Vaisakh Rajan, Shruti Sharma, Charlie Liu, Richard Carpenedo, Shri Joshi, Elizabeth Csaszar, Emily Titus, Chris Bond
Journal: Blood (2024)
Immune Profiling Reveals Distinct Features of Multiple Myeloma Subtypes Defined By Multi-Omics Network Analysis
Authors: Junia Vieira, Alison S Park, Edgar Gonzalez-Kozlova, David Melnekoff, Sherry Bhalla, Chaitanya Acharya, Mark Hamilton, George Mulligan, Immune Atlas Network, Hearn Jay Cho, Li Ding, Sacha Gnjatic, Ioannis S Vlachos, Manoj Bhasin, Sundar Jagannath, Samir Parekh, Alessandro Lagana
Journal: Blood (2024)
<i>PPM1D</i> Somatic Mutations in Myeloid Neoplasms: Clinical Profile, Clonal Characteristics and Impact of Concurrent Somatic <i>TP53</i> Mutations
Authors: Talha Badar, Mobachir El Kettani, Kashish J. Shah, Terra L. Lasho, Yael Kusne, Christy M Finke, James M. Foran, Mohamed A. Kharfan-Dabaja, Hemant S. Murthy, Yao-Shan Fan, Liuyan Jiang, Naseema Gangat, Abhishek A. Mangaonkar, Aref Al-Kali, Ludovica Marando, Ayalew Tefferi, Rong He, David Viswanatha, Mark R. Litzow, Mrinal M. Patnaik
Journal: Blood (2024)
The Argument for Targeted Therapy in <i>IDH1</i> Mutated Myelodysplastic Syndromes (MDS): Poor Outcomes Post-Hypomethylating Agent Failure in Higher Risk MDS and Reduced Leukemia Free Survival in Lower Risk MDS
Authors: Ziad Abuhelwa, Najla H. Al Ali, Zhuoer Xie, Onyee Chan, Seongseok Yun, Andrew T. Kuykendall, Alison R. Walker, Jeffrey E Lancet, Eric Padron, David Sallman, Rami S. Komrokji
Journal: Blood (2024)
PAX5 Loss Compromises CD22 Protein Levels and Responses to Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia
Authors: Jacinta Davis, JuanCarlos Balandrán, Katharina Hayer, Sisi Zheng, Zhiwei Ang, Evelyn Liu, Bonnie Yates, Nirali N. Shah, Iannis Aifantis, Andrei Thomas-Tikhonenko
Journal: Blood (2024)
Indolent CD8+ CAR T-Cell Lymphoma of the Gastrointestinal Tract after Ciltacabtagene Autoleucel Therapy for Relapsed/Refractory Multiple Myeloma
Authors: Hitomi Hosoya, Sebastian Fernandez-Pol, John Gubatan, Zachary Ehlinger, Claire Lohman, Armando N Bastidas Torres, Safa Najidh, Alexa Kwang, George Duran, Charles Wright III, Vanessa E. Kennedy, Sushma Bharadwaj, Melody Smith, Saurabh Dahiya, Matthew J. Frank, Lori Muffly, Wen-Kai Weng, Bita Sahaf, David Kurtz, Crystal L. Mackall, Michael S. Khodadoust, David B. Miklos, Surbhi Sidana, Lekha Mikkilineni
Journal: Blood (2024)
Neutrophil to Lymphocyte Ratio Is an Independent Prognostic Marker in Myelodysplastic Syndromes
Authors: Rami S. Komrokji, Zena Komrokji, Najla H. Al Ali, Zhuoer Xie, Onyee Chan, Andrew T. Kuykendall, Joseph E. Jabbour, Alison R. Walker, Jeffrey E Lancet, Eric Padron, David Sallman
Journal: Blood (2024)
Patient Characteristics and Treatment Patterns for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) By CAR T Eligibility and Treatment Status in France, Germany, Italy, Spain, the UK, and Japan
Authors: Andrew Park, Selin Cooper, Sheila Mpima, Vicky Casey, Moulika Chatu, Ângela Nunes, Fil Manuguid, Alexander Liede
Journal: Blood (2024)
Golcadomide (GOLCA) ± Rituximab (RTX) Demonstrates Durable Efficacy and Is Well Tolerated in Patients (pts) with Relapsed/Refractory Follicular Lymphoma (R/R FL): Updated Results from the Phase 1/2 CC-99282-NHL-001 Study
Authors: Julio C. Chavez, Guilherme Fleury Perini, Loretta Nastoupil, Judit Mészáros Joergensen, Pierre Bories, Bijou Fontanet, Pier Luigi Zinzani, Javier Munoz, Daniel Morillo Giles, Cecilia Carpio, Abel Costa, Won Seog Kim, Parth Rao, Bérengère de Moucheron, Yang Gang, Carla Guarinos, Akshay Sudhindra, Michael Pourdehnad, Jean-Marie Michot
Journal: Blood (2024)
Protein S Enhances the Phagocytosis of Phosphatidylserine-Positive Erythrocyte: Implications for the Erythrocytes Turnover
Authors: Claire Auditeau, Aurelie Fricot-Monsinjon, Raphaël Gauthier, Zeynep Cacan, Céline Gounou, Alain Brisson, Laure Joseph, Sandra Manceau, Mariem Khamari, Sophie Moog, Pierre Buffet, Laetitia Claer, Sandrine Laurance, Valentine Brousse, Delphine Borgel, Francois Saller, Camille Roussel
Journal: Blood (2024)
Targeting the Membrane-Proximal Domain of CD33 to Maximize the Efficacy of Natural Killer Cell-Based Immunotherapies
Authors: Sheryl Y. T. Lim, Frances M. Cole, George S. Laszlo, Margaret C. Lunn-Halbert, Jenny Huo, Junyang Li, Allie R. Kehret, Roland B. Walter
Journal: Blood (2024)
Risk Factors for Suboptimal Treatment in Patients with Newly Diagnosed Multiple Myeloma across US Healthcare Systems
Authors: Geethika Bodanapu, June Corrigan, John Culnan, Maya Srinivasan, Mehar Hora, Alexander Lazzaro, Cenk Yildirim, Danne Elbers, Deborah Lang, Nhan V. Do, Mary T. Brophy, Britney Bell, Raphael E. Szalat, Nikhil C. Munshi, Nathanael R. Fillmore, Camille V. Edwards
Journal: Blood (2024)
Impact of TP53 Mutation on Survival Outcomes in Acute Lymphoblastic Leukemia at a Tertiary Center
Authors: Meera Patel, Ahmed N Mohamed, Hadil Zureigat, Emily C. Zabor, Daniel P. Nurse, Yohana B. Bedelu, Mark Jinan Chen, Joy Nakitandwe, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Sudipto Mukherjee, Hetty E. Carraway, Anjali S. Advani, Moaath K. Mustafa Ali
Journal: Blood (2024)
Treatment Duration and Risk of Fatal Infections in Patients with B-Cell Non-Hodgkin Lymphoma Achieving Complete Response with Odronextamab
Authors: Gottfried von Keudell, Eliza A. Hawkes, Cecilia Carpio, Max S. Topp, Biyi Shen, Jingjin Li, Claire Hearnden, Saleem Shariff, Hesham Mohamed, Srikanth Ambati, Aafia Chaudhry, Sabarish Ayyappan
Journal: Blood (2024)
Integrative Analysis of Transcriptomic and Proteomic Data Identifies Patterns of Primary Resistance to Venetoclax-Azacitidine and Reveals Targetable Vulnerabilities in Acute Myeloid Leukemia (AML)
Authors: Ida Vänttinen, Joseph Saad, Tanja Ruokoranta, Sari Kytölä, Pia-Sofia Ettala, Marja Pyörälä, Johanna Rimpiläinen, Timo Siitonen, Caroline A. Heckman, Heikki Kuusanmäki, Mika Kontro
Journal: Blood (2024)
Measurable Residual Disease Monitoring for Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ALL) in the Setting of the Gimema ALL2820 Trial
Authors: Marco Beldinanzi, Vittorio Bellomarino, Deborah Cardinali, Irene Della Starza, Mabel Matarazzo, Mariangela Di Trani, Matteo Leoncin, Clara Minotti, Lara Pochintesta, Erika Borlenghi, Caterina Alati, Simona Sica, Valentina Mancini, Barbara Scappini, Bianca Serio, Marina Parisi, Lucia Ammirati, Antonella Cucca, Federico Lussana, Ernesta Audisio, Federico Mosna, Patrizia Zappasodi, Monica Bocchia, Silvia Imbergamo, Mario Luppi, Valeria Cardinali, Crescenza Pasciolla, Claudio Romani, Albana Lico, Benedetta Cambò, Massimiliano Bonifacio, Monica Messina, Daniele G. Mattei, Sara Mastaglio, Lara Aprile, Monia Lunghi, Anna Guarini, Robin Foà, Sabina Chiaretti
Journal: Blood (2024)
Reactivation of p53 in <i>TP53</i>-Y220C Mutant AML: Mechanism of Action and Mechanism-Based Drug Combinations
Authors: Bing Z. Carter, Po Yee Mak, Baozhen Ke, Xiaogang Wu, Steffen Boettcher, Lauren B. Ostermann, Andrea Bedoy, Georgina Gener-Ricos, Jayastu Senapati, Courtney D. DiNardo, Anna Puzio-Kuter, Arnold Levine, Michael Andreeff
Journal: Blood (2024)
FDA Analysis of Race and Ethnic Enrollment of Clinical Trials for Drug Registration in Adult Patients for Leukemia and Myelodysplastic Syndrome
Authors: Ashley C. Woods, Dianne D. Pulte, Kamar Godder, Emily Jen, Nina Kim, Robert Le, Catherine C. Lerro, Donna Rivera, Gulsum Pamuk, Nicole J. Gormley, Marc R. Theoret, Kelly J. Norsworthy, R. Angelo De Claro
Journal: Blood (2024)
Intensity-Adjusted Salvage Chemotherapy Plus FLT3-Inhibitor Gilteritinib in Relapsed/Refractory Acute Myeloid Leukemia with Mutated FLT3-ITD/TKD (SAPPHIRE-G)
Authors: Hawk Kim, Jae-Sook Ahn, Sung-Hyun Kim, Ho-Young Yhim, Sung-Nam Lim, Yoo Jin Lee, Jeong-Ok Lee, Eun-Ji Choi, Je-Hwan Lee
Journal: Blood (2024)
A Real-World Weighted Comparison of Tisagenlecleucel and Axicabtagene Ciloleucel CAR T Cells in Relapsed or Refractory Diffuse Large B Cell Lymphoma Aged 75 Years and Older : A Lysa Study from the Descar-T Registry
Authors: Blandine Guffroy, Emmanuel Bachy, Roberta Di Blasi, Hanane Guedon, Fabien Le Bras, Ibrahim Yakoub-Agha, Stephanie Guidez, Laure Ricard, Thomas Gastinne, Cristina Castilla-Llorente, Justine Decroocq, Gabriel Brisou, Sylvain Choquet, Olivier Casasnovas, Michael Loschi, Jacques-Olivier Bay, Fabrice Jardin, Anne Cuozzo, Elodie Gat, Alexandra Marquet, Steven Le Gouill, Roch Houot, Pierre Bories
Journal: Blood (2024)
Myelodysplastic Neoplasms Patients' and Caregivers' Unmet Needs and Their Impact on Their Quality of Life and Symptoms
Authors: Elena Crisa, Daniela Cilloni, Marta Riva, Enrico Balleari, Daniela Barraco, Lorenza Borin, Michela Calmasini, Anna Calvisi, Isabella Capodanno, Matteo Giovanni Della Porta, Elisa Diral, Bruno Fattizzo, Susanna Fenu, Stefania Paolini, Carlo Finelli, Claudio Fozza, Chiara Frairia, Valentina Giai, Mauro Turrini, Maria Antonia Isoni, Federico Itri, Luca Maurillo, Alfredo Molteni, Giuseppe Alberto Palumbo, Anna Maria Pelizzari, Federica Pilo, Antonella Poloni, Costanza Bosi, Grazia Sanpaolo, Rosaria Sancetta, Cristina Amato, Valeria Santini, Maria Teresa Voso, Sam Salek, Tatyana Ionova, Annamaria Nosari, Esther Natalie Oliva
Journal: Blood (2024)
Combination of CPX-351 and Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Acute Myeloid Leukemia and Post Hypomethylating Agent (HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)
Authors: Jayastu Senapati, Farhad Ravandi, Emmanuel Almanza, Tapan M. Kadia, Guillermo Montalban-Bravo, Stefan Faderl, Koji Sasaki, Nicholas J. Short, Naval Daver, Courtney D. DiNardo, Lucia Masarova, Alessandra Ferrajoli, Fadi G. Haddad, Elias Jabbour, Gautam Borthakur, Sheila Tan, Sherry Pierce, Guillermo Garcia-Manero, Michael Andreeff, Yesid Alvarado Valero
Journal: Blood (2024)
HLTF Regulates Erythroid Differentiation through Transcription Factors and Chromatin Landscape Modulation
Authors: Han Gong, Bin Hu, Wenwen Xu, Pan Wang, Maohua Li, Ling Nie, Huifang Zhang, Li Liu, Yue Sheng, Long Liang, Xu Han, Mohandas Narla, Jing Liu
Journal: Blood (2024)
Allogeneic Hematopoietic Cell Transplantation Promotes Atherosclerosis in Mice Driven By Donor CD8+ T Cells
Authors: Haroon Shaikh, Ivana Jorgacevic, Hla Ali, Maja Bundalo, Sarah Schäfer, Michael AG Kern, Maike Büttner- Herold, Clément Cochain, Antoine-Emmanuel Saliba, Giuseppe Rizzo, Juan Vargas, Louis Boon, Wolfgang Herr, Hermann Einsele, Friederike Berberich-Siebelt, Andreas Rosenwald, Andreas Beilhack, Alma Zernecke
Journal: Blood (2024)
The Anti-Myeloma Efficacy of TAS0612, a Triple Inhibitor of RSK, AKT, and S6K, and Itssynergistic Combination with Venetoclax in Multiple Myeloma Irrespective of Cytogeneticabnormalities
Authors: Haruya Okamoto, Shinsuke Mizutani, Taku Tsukamoto, Yoko Katsuragawa-Taminishi, Yuka Kawaji-Kanayama, Kentaro Mizuhara, Ayako Muramatsu, Reiko Isa, Takahiro Fujino, Yuji Shimura, Koji Ichikawa, Junya Kuroda
Journal: Blood (2024)
A TCR-like CAR T Cell Therapy for the Treatment of MZB1 Positive Multiple Myeloma and Other B-Cell Malignancies
Authors: Elena Maroto Martin, Yingjie Zhao, Sara Mangesh Kolhatkar, Roberto Garcia-Vicente, Mubin Tarannum, Mehmet K. Samur, Mariateresa Fulciniti, Rizwan Romee, Jianzhu Chen, Nikhil C. Munshi
Journal: Blood (2024)
Generation of a Patient Derived T-Cell Prolymphocytic Leukemia Xenograft Model to Evaluate Pre-Clinical Treatment with Small Molecule Inhibitors <i>In Vivo</i>
Authors: Claudia Kettlun, Daniel Galvan, Jie Xu, Tania P Sainz Zuniga, Sebastian Juarez-Casillas, Daisy Y. Diaz Rohena, Vishal Sahu, Juan Andres Donoso, Arrate Zubero, Estela Rojas-Neira, David Blake, Jared Henderson, Michael Green, Tapan M. Kadia, Deepa Sampath, Francisco Vega
Journal: Blood (2024)
Validating Low Flow Cytometry Events with Next-Generation Sequencing for Precise Detection of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia
Authors: Shu-Wei Chou, Meng-Yao Lu, Yung-Li Yang, Hsiu-Hao Chang, Xavier Cheng-Hong Tsai, Chia-Jui Du, Shiann-Tarng Jou
Journal: Blood (2024)
Targeting PERK Arm of Unfolded Protein Response Helps to Eliminate Therapy-Induced Residual Senescent-like Acute Myeloid Leukemia Cells
Authors: Gowri Poigaialwar, Sumiko Takao, Sovira Chaudhry, Laura K. Schmalbrock, Varun Gupta, Alex Kentsis, Julio A. Aguirre-Ghiso, Marina Konopleva, Maria S. Sosa, Anna Skwarska
Journal: Blood (2024)
A Real-World (RW) Analysis of the Relationship between Epstein-Barr Virus (EBV) Positivity and Baseline Characteristics, Treatment Patterns and Clinical Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL)
Authors: Elif Yilmaz, Xiaoliang (Wendy) Wang, Niquelle Brown Wadé, Yu-Lun Liu, Praveen Ramakrishnan Geethakumari, Ahmed Sawas
Journal: Blood (2024)
Efficacy of Anti-BCMA CAR-T Cell Therapies in Multiple Myeloma Patients with Prior Exposure to Bispecific Antibodies- Results from a Retrospective Multi-Center Registry Analysis
Authors: Johannes Waldschmidt, David Fandrei, Vladan Vucinic, Ralph Wäsch, Axel Nogai, Winfried Alsdorf, Annamaria Brioli, Evgenii Shumilov, Fabian Mueller, Raphael Teipel, Nico Gagelmann, Monika Engelhardt, Jan Krönke, Julia Mersi, Michael Hudecek, Martin K. Kortüm, Uwe Platzbecker, Hermann Einsele, Max S. Topp, Leo Rasche, Maximilian Merz
Journal: Blood (2024)
Characteristics and Therapeutic Response of Erdheim-Chester Disease Associated with Myeloid Neoplasm, an Observational Multicenter Study
Authors: Ambroise Le Pogam, Matthias Papo, Pierre Hirsh, Jean-Francois Emile, Pierre Duffau, Jerome Razanamahery, Estibaliz Lazarro, Damiens Roos-Weil, Fleur Cohen-Aubart, Vincent Jachiet, Arsene Mekinian, Olivier Fain, Zahir Amoura, Jerome Hadjadj, Julien Haroche
Journal: Blood (2024)
Prognostic Insights on PRE-Fibrotic Primary Myelofibrosis: A Clinical-Pathological Perspective in 762 Patients
Authors: Daniele Cattaneo, Barbara Mora, Cristina Bucelli, Margherita Maffioli, Elena Maria Elli, Giulia Benevolo, Valentina Bellani, Emilia Scalzulli, Filippo Branzanti, Paola Bianchi, Marta Lionetti, Bruno Martino, Umberto Gianelli, Niccolò Bolli, Francesca Palandri, Massimo Breccia, Dario Consonni, Alessandra Iurlo
Journal: Blood (2024)
Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis
Authors: Yifei Huang, Ren Lin, Shanyu Zhang, Zhiping Fan, Fen Huang, Li Xuan, Na Xu, Hui Liu, Zhixiang Wang, Min Dai, Hua Jin, Jing Sun, Qifa Liu
Journal: Blood (2024)
Gamma Secretase Inhibition May Mitigate the Impact of Low BCMA Target Density in Relapsed/Refractory Multiple Myeloma: Results from a Comparative Analysis of Two Phase 1 Clinical Trials
Authors: Andrew J Portuguese, Sherilyn A. Tuazon, Margot J. Pont, Gabriel Cole, Blythe Duke Sather, Xiaoling Song, Brent L. Wood, Michelle Lee Blake, Melissa Works, Mazyar Shadman, Qian Vicky Wu, Jenna M. Voutsinas, Ted Gooley, Cameron J. Turtle, Brian G. Till, David G. Coffey, David G. Maloney, Edward Libby, Aude G Chapuis, Filippo Milano, Stanley R. Riddell, Andrew J. Cowan, Damian J. Green
Journal: Blood (2024)
Expanded Genome-Wide Association Study (GWAS) Identifies Nine Novel Germline Risk Loci for Waldenström Macroglobulinemia (WM) and Lymphoplasmacytic Lymphoma (LPL)
Authors: Hanla Park, Mary Lou McMaster, Zachary R Hunter, Alyssa I Clay-Gilmour, Lara E. Sucheston-Campbell, Charles Breeze, Joshua Arias, Ólafur Birgir Davídsson, Karl Smith-Byrne, Murat Güler, Brenda M. Birmann, Jonathan Hofmann, Elizabeth E. Brown, Shirley D'Sa, Charles Dumontet, Nathaniel Rothman, Henrik Hjalgrim, James R. Cerhan, Susan L. Slager, Vijai Joseph, James McKay, Steven P. Treon, Sonja I. Berndt
Journal: Blood (2024)
Next-Generation Off-the-Shelf CAR T-Cell Therapy Developed to Eliminate a Broad Spectrum of Pathogenic Cells in Hematological Diseases in the Absence of Conditioning Chemotherapy
Authors: John Goulding, Mark Jelcic, Daniel Morales-Mantilla, John Reiser, Alison O'Connor, Rina Mbofung, Alan Williams, Dan Lu, Bi-Huei Yang, Alma Gutierrez, Miguel Meza, Yijia Pan, Jonatan Tuncel, Bryan Hancock, Sean Sherman, Alec Witty, Eigen Peralta, Martin Hosking, Lilly Wong, Tom Lee, Jode Goodridge, Bahram Valamehr
Journal: Blood (2024)
Cord Blood-Derived Carcik Cells As Off-the-Shelf Non-Viral Cell Therapy for Hematological Malignancies
Authors: Ilaria Pisani, Giusi Melita, Simone Naso, Michele Francesco Quaroni, Giada Matera, Daniela Belotti, Benedetta Cabiati, Elisa Gotti, Carolina Cuofano, Chiara Capelli, Jolanda Sarno, Angela Maria Savino, Ilaria Ratti, Daniele Prati, Benedetta Rambaldi, Giorgio Ottaviano, Giovanna Lucchini, Giuseppe Dastoli, Andrea Biondi, Alessandro Rambaldi, Josee Golay, Martino Introna, Giuseppe Gaipa, Sarah Tettamanti
Journal: Blood (2024)
Tissue-Specific Myeloablative Conditioning with Total Marrow Irradiation Enhances Gut Microbiome Diversity and Mitigates Gvhd: A Novel Therapeutic Approach
Authors: Ji Eun Lim, Srideshikan Sargur Madabushi, Mengistu Lemecha Shukare, Hemendra Ghimire, Jenny Paredes, Sally Mokhtari, James F. Sanchez, Karamjeet S Sandhu, Amandeep Salhotra, Ryotaro Nakamura, Jeffrey Wong, Anthony S. Stein, Dorothy Schaue, Marcel R.M. van den Brink, MHD Monzr M. Al Malki, Guy Storme, Susanta Hui
Journal: Blood (2024)
Phase Ib/II Study of CPX-351 Plus Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
Authors: Vanthana Bharathi, Alex Bataller, Alexandre Bazinet, Gautam Borthakur, Elias Jabbour, Naval Daver, Nicholas J. Short, Koichi Takahashi, Ghayas C. Issa, Courtney D. DiNardo, Naveen Pemmaraju, Nitin Jain, Guillermo Montalban-Bravo, William G. Wierda, Farhad Ravandi, Hagop M. Kantarjian, Tapan M. Kadia
Journal: Blood (2024)
Real-World Multicenter Comparison of Venetoclax and Azacitidine <i>Versus</i> Intermediate or High Dose Cytarabine-Based Salvage for Patients with AML in First Relapse after Front Line Intensive Chemotherapy. a Dataml-IPC-Auraml Consortium Study
Authors: Pierre-Yves Dumas, Sarah Bertoli, Clémence Santana, Mael Heiblig, Thibaut Leguay, Suzanne Tavitian, Eric Delabesse, Émilie Klein, Emmanuelle Tavernier, Martin Carre, Gaspar Aspas Requena, Anne Banos, Norbert Vey, Arnaud Pigneux, Christian Récher, Sylvain Garciaz
Journal: Blood (2024)